COVID-19 vaccines Booster shots approved for those 65 and older The U.S. Food and Drug Administration has authorized Pfizer booster shots for those 65 and older and for people at least 16 years old who are at high risk of severe illness or work in settings where exposure is higher. An FDA advisory panel recommended the booster shot for this group on Sept. 17, and the FDA granted approval